On April 4, the San Diego chapter of Oxbridge Biotech Roundtable (OBR) will present a free event, Personalized Medicine: Road to New Opportunities.
Drug development scientist Rita Lim-Wilby, Ph.D. will lead a panel discussion on this fascinating and quickly evolving topic. The panel includes Michael Jackson, Ph.D., Sanford-Burnham’s vice president of drug discovery and development, Rob Bookstein, M.D., of Illumina, James Christensen, Ph.D., of Pfizer, Ashley Van Zeeland, Ph.D., M.B.A., of Cyber Genomics, and Paul Billings, M.D., Ph.D., of Life Technologies.
What: Personalized Medicine: Road to New Opportunities
When: Thursday, April 4, 2013, 5:15 p.m. PT
Where: W.M. Keck Foundation Amphitheater, The Scripps Research Institute
10550 N. Torrey Pines Rd, La Jolla, CA 92037
“The decreasing cost of whole-genome sequencing has made personalized medicine not just a desirable, but also a viable, option for diagnosing and managing many diseases. This approach could be used for anything from common, chronic diseases such as diabetes to rare or orphan diseases. This technology will also create invaluable ‘big datasets’ that could be used to answer many questions on health and disease,” says OBR Editor-in-Chief Leah Cannon, Ph.D. “We want to discuss the opportunities that this burgeoning sector offers academics, bioentrepreneurs, patients, and families.”
Personalized medicine has taken on an increasing prominence in Sanford-Burnham’s research. Personalized approaches to diagnosis and potential treatments are being employed in cancer, heart disease, and other areas.
OBR is a student-led initiative with a mission to engage academic and industry communities and foster a conversation about the healthcare and life-sciences industry. They host events, maintain an interactive blog, and take on business consulting projects.